retatrutide clinical trial duration Reta data & dosing — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 trials for metabolic health — targeting GLP-1, GIP New Phase 3 retatrutide data

"There has never been a medication or class of medications that has worked for obesity in this way," says Christopher McGowan, MD , an obesity medicine specialist in Cary, North Carolina

The Role of Oxidants and Reactive Nitrogen Species in Irritable Bowel Syndrome: A Potential Etiological Explanation

Biochem Pharmacol 229:116471 [DOI] [PubMed] [Google Scholar] Kelly CA, Sipos JA (2024) Approach to the patient with thyroid nodules: considering GLP-1 receptor agonists

2 Hims & Hers has been one of the most prominent players in the direct-to-consumer GLP-1 space, yet the company has faced its own headwinds in recent months after being required to pull access to compounded semaglutide following FDA action against mass compounding of GLP-1 drugs

Lipid profile changes induced by glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis

Secondly, although the main signal pathways activated by insulin and IGF-1 are the same, PI3K-AKT and MAPK-ERK signal pathways, insulin and IGF-1 have been reported to alter different gene expressions in cellular metabolism (Entingh-Pearsall and Kahn, 2004)